{"name": "Promedior",
 "permalink": "promedior",
 "crunchbase_url": "http://www.crunchbase.com/company/promedior",
 "homepage_url": "http://promedior.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2006,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@promedior.com",
 "phone_number": "610.560.1435",
 "description": "Biopharmaceutical Company",
 "created_at": "Thu Mar 18 00:54:24 UTC 2010",
 "updated_at": "Sat Mar 23 23:31:50 UTC 2013",
 "overview": "\u003Cp\u003EPromedior is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of inflammatory and fibrotic diseases\u003C/p\u003E\n\n\u003Cp\u003EPromedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases.  By specifically targeting these cells at the site of injury, Promedior is able to treat the source of aberrant immune system responses, promote tissue healing and resolution, and greatly reduce the risk of systemic side effects inherent in current therapeutic approaches. \u003C/p\u003E\n\n\u003Cp\u003EPromedior is developing drugs to address the most severe and difficult-to-treat fibrotic and inflammatory conditions of the eye, lung and kidney such as glaucoma, age-related macular degeneration, diabetic retinopathy and dry eye disease; pulmonary fibrosis, scleroderma and COPD; and acute and chronic nephropathy.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       93],
      "assets/images/resized/0008/0744/80744v2-max-150x150.jpg"],
     [[162,
       101],
      "assets/images/resized/0008/0744/80744v2-max-250x250.jpg"],
     [[162,
       101],
      "assets/images/resized/0008/0744/80744v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Suzanne",
      "last_name": "L. Bruhn",
      "permalink": "suzanne-l-bruhn",
      "image":
       {"available_sizes":
         [[[120,
            150],
           "assets/images/resized/0023/7812/237812v1-max-150x150.jpg"],
          [[140,
            175],
           "assets/images/resized/0023/7812/237812v1-max-250x250.jpg"],
          [[140,
            175],
           "assets/images/resized/0023/7812/237812v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Chief Scientific Officer",
    "person":
     {"first_name": "MARK",
      "last_name": "L. LUPHER, JR.",
      "permalink": "mark-l-lupher-jr",
      "image":
       {"available_sizes":
         [[[118,
            150],
           "assets/images/resized/0017/7690/177690v1-max-150x150.jpg"],
          [[124,
            157],
           "assets/images/resized/0017/7690/177690v1-max-250x250.jpg"],
          [[124,
            157],
           "assets/images/resized/0017/7690/177690v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Chief Medical Officer",
    "person":
     {"first_name": "Elizabeth",
      "last_name": "G. Trehu",
      "permalink": "elizabeth-g-trehu",
      "image":
       {"available_sizes":
         [[[120,
            150],
           "assets/images/resized/0023/7813/237813v1-max-150x150.jpg"],
          [[140,
            175],
           "assets/images/resized/0023/7813/237813v1-max-250x250.jpg"],
          [[140,
            175],
           "assets/images/resized/0023/7813/237813v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "President \u0026 Chief Executive Officer",
    "person":
     {"first_name": "DOMINICK",
      "last_name": "C. COLANGELO",
      "permalink": "dominick-c-colangelo",
      "image":
       {"available_sizes":
         [[[118,
            150],
           "assets/images/resized/0017/7689/177689v1-max-150x150.jpg"],
          [[124,
            157],
           "assets/images/resized/0017/7689/177689v1-max-250x250.jpg"],
          [[124,
            157],
           "assets/images/resized/0017/7689/177689v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$50.5M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://www.altassets.com/private-equity-news/article/nz18164.html",
    "source_description": "AltAssets",
    "raised_amount": 12000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 3,
    "funded_day": 17,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Forbion Capital Partners",
         "permalink": "forbion-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0010/0907/100907v1-max-150x150.png"],
             [[200,
               80],
              "assets/images/resized/0010/0907/100907v1-max-250x250.png"],
             [[200,
               80],
              "assets/images/resized/0010/0907/100907v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 14000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 5,
    "funded_day": 24,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Polaris Partners",
         "permalink": "polaris-partners",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0001/1153/11153v1-max-150x150.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-250x250.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HealthCare Ventures",
         "permalink": "healthcare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0004/9268/49268v1-max-150x150.jpg"],
             [[250,
               34],
              "assets/images/resized/0004/9268/49268v1-max-250x250.jpg"],
             [[290,
               40],
              "assets/images/resized/0004/9268/49268v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "Trellis Bioscience",
         "permalink": "trellis-bioscience",
         "image":
          {"available_sizes":
            [[[150,
               116],
              "assets/images/resized/0005/9917/59917v1-max-150x150.png"],
             [[203,
               157],
              "assets/images/resized/0005/9917/59917v1-max-250x250.png"],
             [[203,
               157],
              "assets/images/resized/0005/9917/59917v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Easton Capital",
         "permalink": "easton-capital",
         "image":
          {"available_sizes":
            [[[150,
               51],
              "assets/images/resized/0001/6203/16203v3-max-150x150.jpg"],
             [[208,
               72],
              "assets/images/resized/0001/6203/16203v3-max-250x250.jpg"],
             [[208,
               72],
              "assets/images/resized/0001/6203/16203v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Morgenthaler Ventures",
         "permalink": "morgenthaler-ventures",
         "image":
          {"available_sizes":
            [[[150,
               73],
              "assets/images/resized/0001/2347/12347v1-max-150x150.png"],
             [[221,
               108],
              "assets/images/resized/0001/2347/12347v1-max-250x250.png"],
             [[221,
               108],
              "assets/images/resized/0001/2347/12347v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "d",
    "source_url": "http://www.fiercebiotech.com/story/promedior-lands-215m-d-round-fibrosis-pipeline/2012-03-07?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Promedior lands $21.5M D round for fibrosis pipeline",
    "raised_amount": 21500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 3,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Fibrotic Ventures",
         "permalink": "fibrotic-ventures",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Morgenthaler Ventures",
         "permalink": "morgenthaler-ventures",
         "image":
          {"available_sizes":
            [[[150,
               73],
              "assets/images/resized/0001/2347/12347v1-max-150x150.png"],
             [[221,
               108],
              "assets/images/resized/0001/2347/12347v1-max-250x250.png"],
             [[221,
               108],
              "assets/images/resized/0001/2347/12347v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HealthCare Ventures",
         "permalink": "healthcare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0004/9268/49268v1-max-150x150.jpg"],
             [[250,
               34],
              "assets/images/resized/0004/9268/49268v1-max-250x250.jpg"],
             [[290,
               40],
              "assets/images/resized/0004/9268/49268v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Polaris Partners",
         "permalink": "polaris-partners",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0001/1153/11153v1-max-150x150.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-250x250.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Forbion Capital Partners",
         "permalink": "forbion-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0010/0907/100907v1-max-150x150.png"],
             [[200,
               80],
              "assets/images/resized/0010/0907/100907v1-max-250x250.png"],
             [[200,
               80],
              "assets/images/resized/0010/0907/100907v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Easton Capital",
         "permalink": "easton-capital",
         "image":
          {"available_sizes":
            [[[150,
               51],
              "assets/images/resized/0001/6203/16203v3-max-150x150.jpg"],
             [[208,
               72],
              "assets/images/resized/0001/6203/16203v3-max-250x250.jpg"],
             [[208,
               72],
              "assets/images/resized/0001/6203/16203v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "d",
    "source_url": "http://www.masshightech.com/stories/2012/10/15/daily1-Promedior-takes-in-3M-investment-from-Shire.html",
    "source_description": "Promedior takes in $3M investment from Shire",
    "raised_amount": 3000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 10,
    "funded_day": 15,
    "investments":
     [{"company":
        {"name": "Shire",
         "permalink": "shire",
         "image":
          {"available_sizes":
            [[[150,
               44],
              "assets/images/resized/0009/6378/96378v1-max-150x150.png"],
             [[150,
               44],
              "assets/images/resized/0009/6378/96378v1-max-250x250.png"],
             [[150,
               44],
              "assets/images/resized/0009/6378/96378v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "101 Hartwell Avenue",
    "address2": "",
    "zip_code": "02421",
    "city": "Lexington",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": 42.465782,
    "longitude": -71.263856}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        118],
       "assets/images/resized/0017/7688/177688v1-max-150x150.jpg"],
      [[250,
        196],
       "assets/images/resized/0017/7688/177688v1-max-250x250.jpg"],
      [[450,
        354],
       "assets/images/resized/0017/7688/177688v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}